Healthcare provider profile · identity verified

Neil Johnathon Frey, APRN

Nurse Practitioner · PALM BAY, FL · NPI 1265093074

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	315	56
Atorvastatin Calcium	Atorvastatin Calcium	302	56
Amlodipine Besylate	Amlodipine Besylate	254	40
Potassium Chloride	Potassium Chloride	249	45
Furosemide	Furosemide	227	43
Eliquis	Apixaban	224	35
Donepezil Hcl	Donepezil Hcl	195	30
Lisinopril	Lisinopril	182	31
Memantine Hcl	Memantine Hcl	178	33
Gabapentin	Gabapentin	156	30
Sertraline Hcl	Sertraline Hcl	155	25
Pantoprazole Sodium	Pantoprazole Sodium	154	25
Metoprolol Tartrate	Metoprolol Tartrate	149	26
Clopidogrel	Clopidogrel Bisulfate	143	26
Omeprazole	Omeprazole	142	26
Trazodone Hcl	Trazodone Hcl	138	27
Tamsulosin Hcl	Tamsulosin Hcl	120	21
Carvedilol	Carvedilol	119	20
Metoprolol Succinate	Metoprolol Succinate	117	25
Quetiapine Fumarate	Quetiapine Fumarate	117	23
Rosuvastatin Calcium	Rosuvastatin Calcium	106	20
Losartan Potassium	Losartan Potassium	100	21
Famotidine	Famotidine	96	21
Duloxetine Hcl	Duloxetine Hcl	90	14
Metformin Hcl	Metformin Hcl	86	14
Myrbetriq	Mirabegron	84	12
Hydralazine Hcl	Hydralazine Hcl	78	14
Montelukast Sodium	Montelukast Sodium	78	13
Pravastatin Sodium	Pravastatin Sodium	76	11
Mirtazapine	Mirtazapine	74	13
Buspirone Hcl	Buspirone Hcl	69	suppressed
Levetiracetam	Levetiracetam	67	suppressed
Spironolactone	Spironolactone	64	12
Citalopram Hbr	Citalopram Hydrobromide	63	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	62	suppressed
Tramadol Hcl	Tramadol Hcl	59	18
Loperamide	Loperamide Hcl	57	16
Risperidone	Risperidone	56	suppressed
Amiodarone Hcl	Amiodarone Hcl	54	suppressed
Bumetanide	Bumetanide	51	suppressed
Olanzapine	Olanzapine	51	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Alendronate Sodium	Alendronate Sodium	47	suppressed
Cholestyramine	Cholestyramine (With Sugar)	47	suppressed
Jardiance	Empagliflozin	47	suppressed
Cholestyramine Light	Cholestyramine	44	suppressed
Xarelto	Rivaroxaban	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	suppressed
Simvastatin	Simvastatin	42	suppressed
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Latanoprost	Latanoprost	40	suppressed
Meloxicam	Meloxicam	38	suppressed
Finasteride	Finasteride	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Azithromycin	Azithromycin	33	30
Calcium Acetate	Calcium Acetate	32	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Glipizide	Glipizide	30	suppressed
Glimepiride	Glimepiride	29	suppressed
Nystatin	Nystatin	29	16
Solifenacin Succinate	Solifenacin Succinate	29	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Labetalol Hcl	Labetalol Hcl	28	suppressed
Lorazepam	Lorazepam	28	16
Midodrine Hcl	Midodrine Hcl	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Atenolol	Atenolol	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Digoxin	Digoxin	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	25	suppressed
Ozempic	Semaglutide	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	22
Ezetimibe	Ezetimibe	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Levofloxacin	Levofloxacin	22	15
Rivastigmine	Rivastigmine	22	suppressed
Cephalexin	Cephalexin	21	17
Diltiazem 24hr Er	Diltiazem Hcl	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	19
Ondansetron Hcl	Ondansetron Hcl	20	14
Albuterol Sulfate Hfa	Albuterol Sulfate	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	15
Entresto	Sacubitril/Valsartan	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin	Amoxicillin	16	12
Meclizine Hcl	Meclizine Hcl	16	suppressed
Methylprednisolone	Methylprednisolone	16	11
Warfarin Sodium	Warfarin Sodium	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	15	suppressed
Valsartan	Valsartan	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Baclofen	Baclofen	13	suppressed
Fluorometholone	Fluorometholone	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Letrozole	Letrozole	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Nyamyc	Nystatin	12	suppressed
Restasis	Cyclosporine	12	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	12	suppressed
Topiramate	Topiramate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error